Oxidised and native low-density lipoproteins induce the release of von Willebrand factor from human endothelial cells in vitro

被引:10
作者
Blann, AD [1 ]
Burrows, G
McCollum, CN
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
[2] Stepping Hill Hosp, Dept Chem Pathol, Stockport SK2 7JE, Lancs, England
[3] Univ S Manchester Hosp, Univ Dept Surg, Manchester M20 8LR, Lancs, England
关键词
endothelium; von Willebrand factor; oxidised LDL; atherosclerosis; hypercholesterolemia;
D O I
10.1080/09674845.2003.11783693
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Increased low-density lipoprotein (LDL)-cholesterol is a risk factor-for atherosclerosis - a disease in which damage to the endothelium is believed to be an important early step. Increased levels of the endothelial marker von Willebrand factor (vWF) in the plasma of patients with hypercholesterolaemia and atherosclerosis probably reflect this process. In this study we seek to link the established observation that oxidised LDL-cholesterol is cytotoxic to human umbilical vein endothelial cells (HUVECs) in vitro with the common finding of raised plasma vWF in patients with atherosclerosis by incubating HUVECs with physiological/pathological levels of native and oxidised LDL-cholesterol for up to 48 h. Microphotography revealed morphological changes in the HUVECs within 24 h, becoming severe, at 48 h, which was mirrored by increased levels of vWF (ELISA) and the release of preloaded radioactive (111)indium tracer into culture supernatants. Our data support and extend the hypothesis that oxidised LDL is directly cytotoxic to HUVECs, and, in addition, provide an important link between in vitro studies and clinical studies where endothelial cell markers such as vWF are increased in the plasma of patients with hypercholesterolaemia and atherosclerosis.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 36 条
[1]   THIOBARBITURIC ACID TEST FOR DETECTING LIPID PEROXIDES [J].
ASAKAWA, T ;
MATSUSHITA, S .
LIPIDS, 1979, 14 (04) :401-406
[2]   Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia [J].
Blann, AD ;
Miller, JP ;
McCollum, CN .
ATHEROSCLEROSIS, 1997, 132 (02) :151-156
[3]  
BLANN AD, 1985, MED LAB SCI, V42, P92
[4]   Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells [J].
Blann, AD ;
Lip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) :335-340
[5]  
Blann AD, 1997, AM J HEMATOL, V55, P15, DOI 10.1002/(SICI)1096-8652(199705)55:1<15::AID-AJH3>3.0.CO
[6]  
2-6
[7]   Oxidized-LDL induce apoptosis in HUVEC but not in the endothelial cell line EA.hy 926 [J].
Claise, C ;
Edeas, M ;
Chaouchi, N ;
Chalas, J ;
Capel, L ;
Kalimouttou, S ;
Vazquez, A ;
Lindenbaum, A .
ATHEROSCLEROSIS, 1999, 147 (01) :95-104
[8]  
Davì G, 1998, CIRCULATION, V97, P953
[9]   LDL-INDUCED CYTO-TOXICITY AND ITS INHIBITION BY ANTI-OXIDANT TREATMENT IN CULTURED HUMAN-ENDOTHELIAL CELLS AND FIBROBLASTS [J].
EVENSEN, SA ;
GALDAL, KS ;
NILSEN, E .
ATHEROSCLEROSIS, 1983, 49 (01) :23-30
[10]   LDL-INDUCED CYTOTOXICITY AND ITS INHIBITION BY HDL IN HUMAN VASCULAR SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS IN CULTURE [J].
HESSLER, JR ;
ROBERTSON, AL ;
CHISOLM, GM .
ATHEROSCLEROSIS, 1979, 32 (03) :213-229